Guru Sonpavde, MD, Associate Professor of Medicine
Director, Urologic Oncology, UAB Comprehensive Cancer Center discusses VEGF followed by PD-1 inhibition or PD-1 inhibition followed by VEGF.
VEGF followed by PD-1 inhibition or PD-1 inhibition followed by VEGF
